Release Date: 15/04/24 14:11 Summary: Response to Revised Takeover Offer by Zhaojin Price Sensitive: Yes Download Document 160.56KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%